Founders are often told to keep their head down and build. On today’s TechCrunch Live, you’ll hear how there has to be a balance. On one hand, founders need to stay focused, but they also need access ...

Nov 18 (Reuters) - Benchling, which develops software tools for scientists and pharmaceutical research organizations, has confidentially submitted paperwork with regulators for a stock market listing ...

After picking up $200 million just over six months ago, Benchling isn’t sitting still. The cloud-based R&D platform developer collected another $100 million to help power its global expansion plans.

Benchling, which develops software tools for scientists and pharmaceutical research organizations, has laid off 74 employees, or 9 per cent of its workforce, its spokesperson confirmed on Friday. The ...

:Benchling, which develops software tools for scientists and pharmaceutical research organizations, has confidentially submitted paperwork with regulators for a stock market listing in New York, ...